3Suppliers
0Customers
2Debt Items
0Related Chains

Tenax Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
ORION ORION 92% The amendment also calls for Orion to supply the Company with levosimendan to the extent reasonably necessary or useful to manufacture orally-administered products containing levosimendan for purpose…
ORION-CORPORATION ORION-CORPORATION 92% The amendment also calls for Orion to supply the Company with levosimendan to the extent reasonably necessary or useful to manufacture orally-administered products containing levosimendan for purpose…
PHYXIUS-PHARMA-INC PHYXIUS-PHARMA-INC 90% License Agreement dated September 20, 2013 by and between Phyxius Pharma, Inc. and Orion Corporation.

Tenax Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Tenax Therapeutics, Inc..

Tenax Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
TENX-DEBT-12941 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
TENX-DEBT-12940 Warrants outstanding: 31882671 90% xbrl warrant detail from xbrl 2026-03-31.

Tenax Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Tenax Therapeutics, Inc..

Tenax Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
TENX-OWNER-MARSHALL-WACE-LLP Marshall Wace LLP 95% 13F/ownership overlay lists Marshall Wace LLP; shares held 298,153; ownership 1.73%; value $4.4M; as of 2025-12-31.
TENX-OWNER-BOOTHBAY-FUND-MANAGEMENT-LLC Boothbay Fund Management, LLC 95% 13F/ownership overlay lists Boothbay Fund Management, LLC; shares held 352,206; ownership 2.05%; value $5.2M; as of 2025-12-31.
TENX-OWNER-BVF-INC BVF Inc. 95% 13F/ownership overlay lists BVF Inc.; shares held 339,549; ownership 1.97%; value $5.1M; as of 2025-12-31.
TENX-OWNER-PERCEPTIVE-ADVISORS-LLC Perceptive Advisors Llc 95% 13F/ownership overlay lists Perceptive Advisors Llc; shares held 439,142; ownership 2.55%; value $6.5M; as of 2025-12-31.
TENX-OWNER-IKARIAN-CAPITAL-LLC Ikarian Capital, LLC 95% 13F/ownership overlay lists Ikarian Capital, LLC; shares held 967,600; ownership 5.63%; value $14.4M; as of 2025-12-31.
TENX-OWNER-POINT72-ASSET-MANAGEMENT-L-P Point72 Asset Management, L.P. 95% 13F/ownership overlay lists Point72 Asset Management, L.P.; shares held 423,415; ownership 2.46%; value $6.3M; as of 2025-12-31.
TENX-OWNER-RTW-INVESTMENTS-LP RTW Investments LP 95% 13F/ownership overlay lists RTW Investments LP; shares held 378,346; ownership 2.20%; value $5.6M; as of 2025-12-31.
TENX-OWNER-MILLENNIUM-MANAGEMENT-LLC Millennium Management Llc 95% 13F/ownership overlay lists Millennium Management Llc; shares held 302,473; ownership 1.76%; value $4.5M; as of 2025-12-31.
TENX-OWNER-MORGAN-STANLEY Morgan Stanley 95% 13F/ownership overlay lists Morgan Stanley; shares held 596,376; ownership 3.47%; value $8.9M; as of 2025-12-31.
TENX-OWNER-SIREN-L-L-C Siren, L.L.C. 95% 13F/ownership overlay lists Siren, L.L.C.; shares held 427,141; ownership 2.48%; value $6.4M; as of 2025-12-31.
TENX-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 80 tracked holders.

Tenax Therapeutics, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.